# FDA Inspection 1252745 - Actelion Pharmaceuticals US Inc. - October 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/actelion-pharmaceuticals-us-inc/be6c3f37-5375-4dc0-ab96-f2409d61b246
Source feed: FDA_Inspections

> FDA Inspection 1252745 for Actelion Pharmaceuticals US Inc. on October 28, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252745
- Company Name: Actelion Pharmaceuticals US Inc.
- Inspection Date: 2024-10-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252745 - 2024-10-28](https://www.keypedia.com/records/fda_inspections/actelion-pharmaceuticals-us-inc/42933576-b78e-47aa-9776-8c1f99b939b9)

Company: https://www.keypedia.com/companies/actelion-pharmaceuticals-us-inc/dcd7e330-a940-41bf-bf05-d121684e4612

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c